Dapagliflozin modulates hepatic lipid metabolism through the proprotein convertase subtilisin/kexin type 9/low density lipoprotein receptor pathwayFengyuan Lu, Xiaoyu Yang, Yan Zhang et al.|Diabetes Obesity and Metabolism|2025Cited by 3
Author response for "Dapagliflozin modulates hepatic lipid metabolism through the proprotein convertase subtilisin/kexin type 9/low density lipoprotein receptor pathway"Fengyuan Lu, Xiaoyu Yang, En Li et al.|Unknown|2024Cited by 0
Author response for "Dapagliflozin modulates hepatic lipid metabolism through the proprotein convertase subtilisin/kexin type 9/low density lipoprotein receptor pathway"Fengyuan Lu, Xiaoyu Yang, En Li et al.|Unknown|2025Cited by 0